Bare Metal Stents (BMS) (Coronary Stents) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Bare metal stents (BMS) are uncoated stents that are permanently placed inside the artery. These stents are constructed from a range of metals, including nitinol, stainless steel, and cobalt-chromium. One unit refers to one bare-metal stent system. GlobalData’s Medical Devices sector report provides comprehensive information about the Bare Metal Stents (BMS) (Coronary Stents) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

What are the market dynamics in the bare metal stents pipeline products market?

As of November 2021, 4 pipeline products were in the clinical stage, and 1 product was in the pre-clinical and early development stages each. Less than 10 pipeline products were in the inactive stage. During the same period, based on pipeline products by stage of development, 4 products from AlviMedica Medical Technologies Inc were in the clinical process. Similarly, Nanova, Inc had 1 product in the pre-clinical stage. The US is the leading country in the market based on pipeline products by territory, followed by Japan, Europe and India.

Who are the key players in the bare metal stents pipeline products market?

Key players in the market are Advanced Bifurcation Systems Inc, AlviMedica Medical Technologies Inc, Atrium Medical Corp, MIV Therapeutics Inc, Nanova, Inc, Nexeon MedSystems Inc, Palmaz Scientific Inc (Inactive), Qvanteq AG, Rontis AG, Sree Chitra Tirunal Institute for Medical Sciences & Technology, and Viller Scientific LLC. AlviMedica Medical Technologies Inc is the leading company in the market based on the pipeline products in the clinical stage, while Viller Scientific LLC leads for products in the early development stage.

Company overview:

Advanced Bifurcation Systems Inc: Advanced Bifurcation Systems Inc is a medical device company focusing on technologies enabling and facilitating seamless stenting of all coronary bifurcation disease scenarios. The company manufactured the Stenting System – Bare Metal Stent (BMS) that is intended for the treatment of bifurcation lesions in coronary angioplasties. It is designed to widen and open the narrow coronary arteries to restore blood flow. It is based on Mother/Daughter (MD) Platform Technology. It consists of main and side branch stents that are independent, moveable, modular bifurcating stenting systems at the carina or fixed point of a bifurcation. It covers branch angles, sizes, and plaque locations. It features mechanically fail-safe, has no torqueing or micro alignment, no gaps and/or overlaps and reduces the risk of restenosis and thrombosis.

AlviMedica Medical Technologies Inc: AlviMedica Medical Technologies Inc (AlviMedica) is a medical device company that provides minimally invasive medical technologies. The company offers interventional cardiology and endovascular products. Its interventional cardiology products comprise tens, balloons, catheters, and guide wires. AlviMedica offers endovascular products such as renal region products, iliac region systems, femoro-popliteal region, and below-the-knee region products. The company develops minimally invasive medical technologies for medical professionals. It has its presence in Turkey, Italy, France, the Netherlands, Holland, India, China, Singapore, Brazil, Uruguay, Japan, the UK, the US, and others. AlviMedica is headquartered in Istanbul, Turkey.

Atrium Medical Corp: Atrium Medical Corp (Atrium Medical) a subsidiary of Getinge AB, is a medical device company that designs, develops, and manufactures diversified medical devices. The company provides ventricular assist device components, minimally invasive gastrointestinal, devices, arterio-venous access and peripheral by-pass devices, endovascular devices, coronary and peripheral angioplasty and stent deployment catheters, artificial heart components, soft tissue repair and support components, and balloon catheter components. Its services include research and development, manufacturing, customer service, clinical education, professional marketing and sales, and logistics services. Atrium Medical also provides clinical trials and management services. The company operates in Australia, Germany, the Netherlands, and the US. Atrium Medical is headquartered in Hudson, New Hampshire, the US.

The company manufactured the Next Generation Super Flexible Cobalt Chromium Coronary Stent that is intended to be used during percutaneous transluminal coronay angioplasty procedure to treat atherosclerosis. It is designed to widen and open the narrow coronary artery and restore the blood flow. It is stronger and more radiopaque than stainless steel, giving cobalt chromium stents thinner struts with good visibility.

MIV Therapeutics Inc: MIV Therapeutics Inc (MIVT) is a research and development company that develops biocompatible coatings for stents and other medical devices and advanced drug delivery systems. The company focuses on providing healing solutions for cardiovascular disease and other medical conditions. The company’s hydroxyapatite (“HAp”) based product the VESTAsync coronary drug-eluting stent system is in animal studies and human clinical trials. The company has collaborations with The University of British Columbia. It has developed coating technologies that utilize HAp for application on drug delivery systems and medical devices. The company also sells the GenX bare-metal coronary stent in Europe. The company is headquartered in Vancouver, British Columbia, Canada. The company manufactured Vestapor that is a next generation bare metal stent intended for the treatment of coronary artery disease. It is designed to widen and open the narrowed coronary arteries. It is based on the HAp Coating Technology.

Nexeon MedSystems Inc: Nexeon MedSystems Inc (Nexeon) is a bioelectronics company that develops and commercializes devices and therapies for the treatment of cardiovascular diseases. The company’s products include embolic protection systems, local drug, and biologic delivery systems, nanotechnology-based devices, and cell delivery and regenerative therapy devices. It develops anatomy-specific combination embolic protection and stent delivery systems for endovascular procedures. Nexeon also develops cell delivery and regenerative therapies for the delivery of stem cells and biologics to target end-organ sites in order to treat conditions such as acute myocardial infarction, chronic congestive heart failure, and chronic critical limb ischemia. The company offers its products across the US. Nexeon is headquartered in Dallas, Texas, the US.

Sree Chitra Tirunal Institute for Medical Sciences & Technology: Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST), formerly Sree Chitra Tirunal Medical Center, is a healthcare institute that offers medical device development, patient care, and health sciences studies. The institute’s activities include research and development in biomedical engineering and technology deliver high-quality patient care in selected specialties and subspecialties develop postgraduate training programs in advanced medical specialties, biomedical engineering, and technology, and participating in public health reforms through research, training, and interventions. It operates various departments including administrative and support services, anesthesiology, biochemistry, cardiology, clinical engineering, imaging sciences and intervention radiology, microbiology, neurology, neurosurgery, physical medicine and rehabilitation, transfusion medicine, and others. SCTIMST is headquartered in Thiruvananthapuram, Kerala, India.

The company manufactured Bare Metal Coronary Stent that is intended to be used during percutaneous transluminal coronary angioplasty procedures. It is designed to widen and open the narrow blood vessels to restore blood flow

Bare metal stents pipeline products, by key players

To know more about key players, download a free report sample

Market report scope

Scope

• Extensive coverage of the bare metal stents under development.
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities.
• The report reviews the major players involved in the development of bare metal stents and lists all their pipeline projects.
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage.
• The report provides key clinical trial data of ongoing trials specific to pipeline products.
• Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

• Formulate significant competitor information, analysis, and insights to improve R&D strategies.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Identify and understand important and diverse types of bare metal stents under development.
• Develop market-entry and market expansion strategies.
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
• In-depth analysis of the product’s current stage of development, territory, and estimated launch date.